PAE: Q2 Earnings Insights
Shares of PAE (NASDAQ:PAE) were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share decreased 11.76% over the past year to $0.15, which missed the estimate of $0.17.
Deluxe: Q2 Earnings Insights
Shares of Deluxe (NYSE:DLX) were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share rose 8.70% over the past year to $1.25, which beat the estimate of $0.97.
Recap: Himax Technologies Q2 Earnings
Shares of Himax Technologies (NASDAQ:HIMX) rose 7.0% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share rose 6100.00% year over year to $0.62, which beat the estimate of $0.46.
Recap: Prestige Consumer Q1 Earnings
Shares of Prestige Consumer (NYSE:PBH) were unchanged after the company reported Q1 results.
Quarterly Results
Earnings per share were up 32.56% over the past year to $1.14, which beat the estimate of $0.87.
Recap: ACI Worldwide Q2 Earnings
Shares of ACI Worldwide (NASDAQ:ACIW) were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share were down 30.30% year over year to $0.23, which beat the estimate of $0.08.
WESCO International: Q2 Earnings Insights
Shares of WESCO International (NYSE:WCC) were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share rose 153.85% over the past year to $2.64, which beat the estimate of $1.90.
Recap: Fiverr International Q2 Earnings
Shares of Fiverr International (NYSE:FVRR) decreased 22.8% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 90.00% over the past year to $0.19, which beat the estimate of $0.10.
Recap: YETI Holdings Q2 Earnings
Shares of YETI Holdings (NYSE:YETI) decreased 0.7% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 65.85% year over year to $0.68, which beat the estimate of $0.55.
Recap: Iron Mountain Q2 Earnings
Shares of Iron Mountain (NYSE:IRM) remained unaffected after the company reported Q2 results.
Quarterly Results
Earnings per share were down 56.32% year over year to $0.38, which beat the estimate of $0.35.
Moderna Sold Less Than Expected mRNA COVID-19 Vaccine Jabs In Q2; Sees $20B In FY21 Product Sales
Moderna Inc (NASDAQ:MRNA) reports Q2 EPS of $6.46, a turnaround from EPS loss of $(0.31) a year ago, beating the…